Cystic fibrosis drug Orkambi 'approved for use among 6-11 year olds'
The pharmaceutical firm making cystic fibrosis drug Orkambi says it has received EU approval to treat children. Manufacturer Vertex says...
Potential Nitric Oxide Treatment for Resistant Bacterial Infections Gets Patent, May Start Clinical
A possible inhalable treatment for antibiotic-resistant bacterial infections in people with cystic fibrosis due to Pseudomonas aeruginosa...
Introduction of New Therapies Affects Pregnancy Rates in Women With CF, Study Reports
The overall rate at which women with cystic fibrosis are becoming pregnant dropped slightly in recent years — coinciding with the...
2nd Middle East Cystic Fibrosis Conference
Time is running out to take advantage of early registration discounts for the upcoming MECFC 2018 taking place in Izmir, Turkey in March....
Cancer gene plays key role in cystic fibrosis lung infections
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But...
Why Aspiration Is a Silent, Hidden Danger for Cystic Fibrosis Patients
Dr. Gwen A. Huitt is an infectious disease doctor at National Jewish Health with a special interest in mycobacteria, bronchiectasis, and...